Mucosal healing, determined by ileocolonoscopy, is a goal for treatment of Crohn's disease (CD), but this is an invasive assessment procedure. We investigated whether response to tumor necrosis factor (TNF) antagonists, determined by small-intestine contrast ultrasonography, associates with long-term outcomes.
Zorzi, F., Ghosh, S., Chiaramonte, C., Lolli, E., Ventura, M., Onali, S., et al. (2019). Response assessed by Ultrasonography as Target of Biological Treatment for Crohn's disease: Treat to target in CD using Ultrasonography. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY [10.1016/j.cgh.2019.10.042].
Response assessed by Ultrasonography as Target of Biological Treatment for Crohn's disease: Treat to target in CD using Ultrasonography
Onali, SaraMembro del Collaboration Group
;Fantini, Massimo CMembro del Collaboration Group
;Biancone, LiviaMembro del Collaboration Group
;Monteleone, GiovanniMembro del Collaboration Group
;Calabrese, Emma
2019-12-19
Abstract
Mucosal healing, determined by ileocolonoscopy, is a goal for treatment of Crohn's disease (CD), but this is an invasive assessment procedure. We investigated whether response to tumor necrosis factor (TNF) antagonists, determined by small-intestine contrast ultrasonography, associates with long-term outcomes.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
